BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24399654)

  • 1. [Flagellate dermatitis after bleomycin chemotherapy in a patient with malignant germ cell tumor].
    Schummer C; Winkler Y; Tittelbach J; Grimm MO; Elsner P
    Dtsch Med Wochenschr; 2014 Jan; 139(3):84-6. PubMed ID: 24399654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flagellate erythema.
    Eungdamrong J; McLellan B
    Dermatol Online J; 2013 Dec; 19(12):20716. PubMed ID: 24365007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin-induced flagellate dermatitis.
    Wolf R; Wolf D
    Int J Dermatol; 2011 May; 50(5):546-7. PubMed ID: 21506969
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
    J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin-Induced Flagellate Dermatitis.
    Imhof RL; Tollefson MM
    Mayo Clin Proc; 2019 Feb; 94(2):371-372. PubMed ID: 30711138
    [No Abstract]   [Full Text] [Related]  

  • 6. Bleomycin induced flagellate erythema in a patient with thalamic mixed germ cell tumour: Report of a rare adverse effect.
    Biswas A; Julka PK
    J Egypt Natl Canc Inst; 2016 Jun; 28(2):129-32. PubMed ID: 27106629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bleomycin induced flagellate dermatitis: a new clinical case].
    Narimane S; Errihani H
    Pan Afr Med J; 2016; 25():86. PubMed ID: 28292049
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
    Pizzocaro G
    Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
    [No Abstract]   [Full Text] [Related]  

  • 10. Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer.
    Kawai K; Akaza H
    Cancer Sci; 2010 Jan; 101(1):22-8. PubMed ID: 19922501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment results of stage III germinal testicular tumors.
    Akdaş A; Kirkali Z; Altuğ U; Ilker Y
    Turk J Pediatr; 1984; 26(1-4):301-6. PubMed ID: 6085662
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flagellate erythema secondary to bleomycin.
    Khaliq W; Antonarakis ES
    QJM; 2012 Sep; 105(9):901. PubMed ID: 21865305
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bleomycin-induced pneumonia].
    Berger K; Göpfert A; Berkel H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Nov; 31(9):577-81. PubMed ID: 9063925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
    Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F
    Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy for metastatic germ cell tumours of the testis].
    Culine S
    Rev Prat; 2007 Feb; 57(4):385-8. PubMed ID: 17455740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
    Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ;
    J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma.
    Peckham MJ; Horwich A; Blackmore C; Hendry WF
    Cancer Treat Rep; 1985 May; 69(5):483-8. PubMed ID: 2408750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
    Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.